Brief: Passage Bio Reports First Quarter 2022 Financial Results And Provides Recent Business Highlights
Passage Bio Inc PASG.O :
* PASSAGE BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES RECENT BUSINESS HIGHLIGHTS
* Q1 LOSS PER SHARE $0.79
* EXPECTS CURRENT CASH AND CASH EQUIVALENTS TO FUND
OPERATIONS
INTO THE SECOND QUARTER OF 2024
* QTRLY LOSS PER SHARE $0.79
* Q1 EARNINGS PER SHARE VIEW $-0.89 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX71YYZF
Further company coverage: PASG.O